Head of Thoracic Cancer, Global Marketing, Oncology Business Unit
Boston, MA (On-site)
$256K/yr – $402K/yrSenior Level15+ years expFull time
Posted 4 days ago
Job Summary
Original Job Description
Takeda
We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society.We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities.Read our community guidelines: https://takeda.info/communityguidelines
Marketing team
1,941
Employees
37K
Headquarters
Tokyo, Tokyo, JPN
Founded
–
Traffic Signals
Monthly Visitors
586.5K
Monthly Google Ads Budget
$3.3K
Traffic Source Mix
Search
49%
Direct
38.4%
Referral
8.4%
Social
2.1%
Paid
1.9%
Headcount Trend
Current headcount: ~37.2K
Funding
Total Funding
$2.5B
Last Raise
9 months ago
Last Raise Amount
$2.4B
- 2025-06-27Post IPO Debt • $2.4B
- 2016-09-01Grant • $19.8M
- 2016-05-08Grant • $38.0M
Recent News
Fierce Biotech
ASH: Merck mulls future of polycythemia program while Takeda takes phase 3 victory lap
Dec 8, 2025
Yahoo Finance
Takeda Pharmaceutical (TSE:4502): Exploring Valuation After Recent Shareholder Gains
Nov 22, 2025
Fierce Pharma
FDA launches investigation into Takeda's Adzynma following reported pediatric death
Nov 21, 2025
Reuters
US FDA investigates Takeda's blood disorder drug after pediatric death
Nov 21, 2025
BioSpace
FDA Probing Patient Death Linked to Takeda’s Enzyme Replacement Therapy
Nov 21, 2025
Takeda Pharmaceuticals
Setting a sustainable course for the pharma industry | Takeda Stories
Nov 13, 2025
Fierce Biotech
Neurocrine's depression drug is latest asset from Takeda pact to flunk a phase 2 trial
Nov 11, 2025
PRWeek
Former FDA comms director James-Denton Wyllie joins Takeda Pharmaceuticals
Nov 10, 2025
Yahoo Finance
Takeda Pharmaceutical (TSE:4502): Assessing Valuation After Subtle Share Price Changes
Nov 8, 2025
Applied Clinical Trials Online
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
Nov 4, 2025
Clinical Trials Arena
Takeda’s dengue vaccine offers seven-year protection in pivotal trial
Nov 3, 2025
Yahoo Finance
Takeda Pharmaceutical (TSE:4502) Margin Miss Reinforces Bearish Narratives After ¥250.7B One-Off Loss
Nov 1, 2025
Fierce Pharma
Fierce Pharma Asia—Takeda pipeline cuts; Innovent, Lilly win against semaglutide; Roche's bispecific deal
Oct 31, 2025
Yahoo Finance
Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filings This Fiscal Year
Oct 30, 2025
Fierce Biotech
Takeda drops AstraZeneca-partnered neurological program after phase 2 failure
Oct 30, 2025
Oncology Pipeline
Takeda discloses pivotal Innovent plans | ApexOnco - Clinical Trials news and analysis
Oct 30, 2025
FirstWord Pharma
Takeda's shares fall as it trims full-year guidance, pipeline
Oct 30, 2025
Inside Precision Medicine
In a Potential Mega Deal, Takeda Buys Innovent Cancer Candidates
Oct 29, 2025
FirstWord Pharma
Takeda, TetraScience set SAIL on AI-powered drug discovery
Oct 24, 2025
Pharmaceutical Technology
Takeda signs deal worth up to $11.4bn with Innovent for cancer drug hopefuls
Oct 23, 2025
MedCity News
Takeda Boosts Pipeline and Revenue Growth Prospects With $1.2B Deal for Innovent Cancer Drugs
Oct 22, 2025
The Wall Street Journal
China’s Innovent Strikes Cancer Drug Deal With Takeda for Up to $11.4 Billion - WSJ
Oct 22, 2025
Fierce Biotech
Takeda pays Innovent $1.2B upfront, offers whopping $10B-plus in biobucks for cancer assets
Oct 22, 2025
Contract Pharma
Takeda Licenses Late-Stage Cancer Drugs from Innovent in $1.2 Billion Deal
Oct 22, 2025
BioPharma Dive
Takeda stakes more than $11B on cancer drugs from China
Oct 22, 2025
Yahoo Finance
China's Innovent signs cancer therapy deal with Japan's Takeda
Oct 22, 2025
BioSpace
Takeda Bets up to $11.4B for Up To Three Innovent Cancer Assets
Oct 22, 2025
FirstWord Pharma
Takeda pays $1.2B upfront to transform oncology pipeline with two Innovent drugs
Oct 21, 2025
Yahoo Finance
Takeda Pharmaceutical Company (TAK) Signs a Research Partnership with Nabla Bio
Oct 21, 2025
Business Wire
Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors
Oct 21, 2025
Yahoo Finance
Does Takeda Offer Value After Latest FDA Approval and Share Price Dip in 2025?
Oct 19, 2025
Pharmaceutical Technology
Nabla Bio expands Takeda collab for protein therapeutics
Oct 15, 2025
Business Wire
Nabla Bio Signs Second Takeda Collaboration to Advance AI-Driven Design of Protein Therapeutics
Oct 14, 2025
Reuters
US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership
Oct 14, 2025
BioSpace
Takeda Makes $1B+ AI Bet With Nabla to Build Out Early Pipeline
Oct 14, 2025
Fierce Biotech
Takeda turns to AI drug designer for $1B biobucks deal after whittling down R&D focus
Oct 14, 2025
C&EN
AI-based protein discovery start-up strikes a second deal with Takeda
Oct 14, 2025
Los Angeles Business Journal
Takeda Opens $170 Million Expansion
Oct 13, 2025
Yahoo Finance
Takeda Pharmaceutical (TSE:4502): Is the Market Missing Its True Valuation Potential?
Oct 9, 2025
BioSpace
How Takeda Built Its Cell Therapy Portfolio, Only To Walk Away
Oct 8, 2025
Wicked Local
Biopharmaceutical company Takeda to lay off more than 130 employees in Cambridge
Oct 7, 2025
Takeda Pharmaceuticals
Takeda calls for more Plasma Donations During International Plasma Awareness Week
Oct 7, 2025
Informatica
Takeda brings clinical data to life for AI
Oct 7, 2025
Takeda Pharmaceuticals
Aiming to stop Crohn's disease before it starts | Takeda Stories
Oct 6, 2025
Yahoo Finance
Bristol-Myers Squibb, Takeda, Astex Join AI Consortium to Train OpenFold3 for Accelerated Drug Discovery
Oct 3, 2025
Takeda Pharmaceuticals
気候変動に柔軟に対応する:2025年度CSRプログラム | 武田薬品
Oct 3, 2025
PharmExec.com
Takeda Announces Decision to Discontinue Cell Therapy Research
Oct 2, 2025
BioSpace
Takeda Exits Cell Therapy Amid Strategic Pivot, Dealing Blow to Once Promising Modality
Oct 2, 2025
Clinical Trials Arena
Takeda walks away from cell therapy in priority U-turn
Oct 2, 2025
Oncology Pipeline
Takeda’s cancer prospects dim further | ApexOnco - Clinical Trials news and analysis
Oct 2, 2025
FirstWord Pharma
Takeda to cut 137 staffers after cell therapy exit
Oct 2, 2025
日本経済新聞
武田薬品、「細胞療法」の研究開発を中止 減損580億円計上見込み
Oct 1, 2025
Ventura County Star
Takeda unveils $170M expansion in Thousand Oaks
Oct 1, 2025
Fierce Biotech
UPDATED: Takeda lays off 137 US staff as part of retreat from cell therapy
Oct 1, 2025
BioPharma Dive
Takeda, in reversal, abandons cell therapy research
Oct 1, 2025
Reuters
Takeda Pharmaceutical to exit cell therapy research
Oct 1, 2025
Yahoo Finance
Takeda Pharmaceutical to exit cell therapy research
Oct 1, 2025
FirstWord Pharma
Curtain closes on Takeda's cell therapy efforts
Oct 1, 2025
日本経済新聞
武田薬品、血液製剤工場建設1年以上遅れ 建設費高騰で計画見直し
Sep 30, 2025
BioSpace
September’s FDA Action Bolsters Keytruda, Ultra-Rare Disease but Deals Two SMA Defeats
Sep 29, 2025
BioSpace
6 FDA Decisions to Watch For in Q4
Sep 29, 2025
IndiaTimes
Asian drug market stocks slides: Trump’s 100% pharmaceutical tariffs shake market; broader impact on Japan likely minimal
Sep 26, 2025
Boston Globe
Trump’s drug tariffs are days away. Massachusetts’ pharma companies aren’t worried.
Sep 26, 2025
MarketScreener
Shares of Asian drugmakers drop after Trump threatens tariffs
Sep 26, 2025
Takeda Pharmaceuticals
Plasma donation powers rare disease treatments | Takeda Stories
Sep 25, 2025
Investing.com
Shares of Asian drugmakers drop after Trump threatens tariffs
Sep 25, 2025
BioSpace
6 Companies Hiring Now in Pennsylvania
Sep 25, 2025
日経BP
武田薬品、「貨物帆船」で医薬品を輸送、仏企業と提携 - ニュース - メガソーラービジネス plus
Sep 24, 2025
転職×天職
【工場探訪:くすりづくりの現場を歩く】武田薬品工業・光工場―生産量の約半分を海外に輸出、デジタルによる業務改善・効率化随所に
Sep 24, 2025
PharmiWeb
20,000 + Takeda Employees Voted to Select Four New Global...
Sep 24, 2025
PR Newswire UK
Economist Impact's 5th edition Future of Health Asia returns to Singapore amid rising technological disruption, chronic disease burdens and international trade tensions
Sep 23, 2025
thecanadianpressnews.ca
20,000 + Takeda Employees Voted to Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems in 94 Countries
Sep 23, 2025
FierceBiotech
Japan biotech inks research pact in effort to develop new RNA meds
Sep 19, 2025
Clean Technica
Wind-Powered Trimaran Cargo Ship To Be Launched In 2026
Sep 19, 2025
FiercePharma
Takeda scientists tackle Mount Fuji to advocate for patients in need of plasma-derived therapies
Sep 19, 2025
European Pharmaceutical Review
Takeda eyes sustainable shipping with wind-powered sea freight
Sep 18, 2025
MarketScreener
Takeda Uses AI To Forecast Drug Demand, Cut Waste
Sep 17, 2025
PharmaVoice
From atop Mt. Fuji, a Takeda team heralds a need for human plasma
Sep 16, 2025
BioWorld Financial Watch
Regulatory actions for Sept. 16, 2025
Sep 16, 2025
FiercePharma
FDA targets Lilly, Novartis, BMS and more in deluge of marketing letters
Sep 16, 2025
AETOSWire
Takeda and VELA to Ship Medicines Across the Atlantic Using First-of-its-Kind Wind-Powered Trimaran
Sep 16, 2025
PharmiWeb
Takeda and VELA to Ship Medicines Across the Atlantic Using First-of-its-Kind Wind-Powered Trimaran
Sep 16, 2025
thefly.com
Takeda, Vela Transport announce medicine shipping partnership
Sep 16, 2025
日経ビジネス電子版
[新連載]武田薬品、急ピッチで進む「米国化」の実相 ボストンに全集中
Sep 12, 2025
Fierce Biotech
Takeda taps longtime Lilly exec as US head—Chutes & Ladders
Sep 12, 2025
BioSpace
Takeda Appoints Rhonda Pacheco President of the U.S. Business Unit
Sep 12, 2025
Seattle TechFlash
Former URI basketball star to lead Takeda's US operations
Sep 12, 2025
Business Wire
Takeda Appoints Rhonda Pacheco President of the U.S. Business Unit
Sep 11, 2025
Seattle TechFlash
Former URI basketball star jumps from Eli Lilly to Takeda
Sep 11, 2025
MarketScreener
Takeda Announces Executive Changes, Effective September 29
Sep 11, 2025
EIN Presswire
United States Digestive Health Market Set to Soar: Key Trends, Innovations, and Growth Opportunities in 2025-2032
Sep 11, 2025
Boston Globe
Takeda recruits Lilly executive to run US operations out of Cambridge
Sep 11, 2025
PharmiWeb
Results of Nanoform Collaborative Study to be Presented a...
Sep 11, 2025
MarketScreener
Takeda Announces Executive Changes, Effective June 2026
Sep 11, 2025
Fierce Pharma
Takeda faces another 'pay-for-delay' antitrust lawsuit, this one from CVS over heartburn drug Dexilant
Sep 10, 2025
PharmiWeb
AGC Biologics Seattle Facility Achieves Milestone Year wi...
Sep 10, 2025
Pharma Letter
Takeda presents positive data from Phase III oveporexton study
Sep 10, 2025
Yahoo Finance
Assessing Takeda Stock After Recent 6% Jump and New FDA Approval for HyQvia Expansion
Sep 9, 2025
MedCity News
Takeda Is Waking Up the Narcolepsy Market With First-in-Class Drug, But Alkermes Is on Its Heels
Sep 8, 2025
Clinical Trials Arena
Takeda and Alkermes share OX2R drug data for narcolepsy
Sep 8, 2025